Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering the right formulation for enhanced drug delivery
Wei-Ren Ke, Rachel Yoon Kyung Chang, Hak‐Kim Chan
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114561-114561
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research
Ho Wan Chan, Stephanie Chow, Xinyue Zhang, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 4
Open Access | Times Cited: 35
A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications
Hend I. Shahin, Lipika Chablani
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104553-104553
Closed Access | Times Cited: 33
Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation
Ho Wan Chan, Xinyue Zhang, Stephanie Chow, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123877-123877
Closed Access | Times Cited: 8
Role of Particle Size in Translational Research of Nanomedicines for Successful Drug Delivery: Discrepancies and Inadequacies
Ho Wan Chan, Stephanie Chow, Xinyue Zhang, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 9, pp. 2371-2384
Closed Access | Times Cited: 15
Natural Products-Based Inhaled Formulations for Treating Pulmonary Diseases
Jiangyan Yong, Hongli Shu, Xiao Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1723-1748
Open Access | Times Cited: 5
Spray freeze dried niclosamide nanocrystals embedded dry powder for high dose pulmonary delivery
Shengyu Zhang, Shen Yan, Kangwei Lu, et al.
Powder Technology (2022) Vol. 415, pp. 118168-118168
Open Access | Times Cited: 20
Integrated continuous manufacturing of inhalable remdesivir nanoagglomerate dry powders: Design, optimization and therapeutic potential for respiratory viral infections
Ho Wan Chan, Hok Wai Lee, Stephanie Chow, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123303-123303
Closed Access | Times Cited: 11
Screening of Mixing Process for Special Medical Formula Food Based on Powder Engineering
Xianyi Zhao, Zhang Lei, Zhen Liu, et al.
Journal of Food Processing and Preservation (2025) Vol. 2025, Iss. 1
Open Access
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy
Petra Party, Márk László Klement, Bianca Maria Gaudio, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 486-486
Open Access
Powder aerosol formulation of Pseudomonas aeruginosa bacteriophage for pulmonary delivery
Vaibhav Pathak, Li Qu, Qi Zhou
International Journal of Pharmaceutics (2025), pp. 125602-125602
Closed Access
Cyclosporine A-loaded chitosan extra-fine particles for deep pulmonary drug delivery: In vitro and in vivo evaluation
Yongpeng Huang, Hui Tang, Dongxin Liu, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 243-256
Closed Access | Times Cited: 9
Spray freeze dried cannabidiol with dipalmitoylphosphatidylcholine (DPPC) for inhalation and solubility enhancement
Waiting Tai, Jonathon C. Arnold, Hak‐Kim Chan, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124235-124235
Open Access | Times Cited: 3
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation
Seyedeh Negin Kassaee, Derek J. Richard, Godwin A. Ayoko, et al.
Nanomedicine (2024) Vol. 19, Iss. 25, pp. 2113-2133
Closed Access | Times Cited: 3
Engineering porous PLGA microparticles for pulmonary delivery of sildenafil citrate
Raul Edison Luna Lazo, Bruna de Paula Oliveira, Alexandre de Fátima Cobre, et al.
Powder Technology (2023) Vol. 430, pp. 118999-118999
Closed Access | Times Cited: 8
Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model
Hang Dong, Meng Gao, Lu Lu, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 3577-3593
Open Access | Times Cited: 7
“Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges
Jinxue Cao, Yuyi Xu, Jian Zhang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105648-105648
Closed Access | Times Cited: 2
Sustained-Release Powders Based on Polymer Particles for Pulmonary Delivery of Beclomethasone Dipropionate in the Treatment of Lung Inflammation
Emanuela Fabiola Craparo, Salvatore Emanuele Drago, Gabriella Costabile, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1248-1248
Open Access | Times Cited: 6
Inhalable spray-dried polycaprolactone-based microparticles of Sorafenib Tosylate with promising efficacy on A549 cells
Khushwant S. Yadav, Hrushikesh C. Raut, Harsh P. Nijhawan
Pharmaceutical Development and Technology (2023) Vol. 28, Iss. 8, pp. 755-767
Closed Access | Times Cited: 6
Quality by design – Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation
Nasser Alhajj, Niall J. O’Reilly, Helen Cathcart
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123151-123151
Open Access | Times Cited: 5
Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing
Chaeho Moon, Sawittree Sahakijpijarn, Esther Y. Maier, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 564-580
Closed Access | Times Cited: 1
Essential considerations towards development of effective nasal antibiotic formulation: features, strategies, and future directions
Sandra Aulia Mardikasari, Gábor Katona, Bence Sipos, et al.
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 611-625
Closed Access | Times Cited: 1
Inhalable dry powder nano-formulations: advancing lung disease therapy-a review
Faiza Naureen, Yasar Shah, Maqsood Ur Rehman, et al.
Frontiers in Nanotechnology (2024) Vol. 6
Open Access | Times Cited: 1
Formulation of Bacteriophage for Inhalation to Treat Multidrug-Resistant Pulmonary Infections
Vaibhav Pathak, Hak‐Kim Chan, Qi Zhou
KONA Powder and Particle Journal (2024) Vol. 42, pp. 200-212
Open Access | Times Cited: 1
Gut microbiome and inflammation in cardiovascular drug response: trends in therapeutic success and commercial focus
Firoz Anwar, Fahad A. Al‐Abbasi, Omar A. Al-Bar, et al.
Inflammopharmacology (2024)
Closed Access | Times Cited: 1
Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A
Yongpeng Huang, Hui Tang, Xiangyan Meng, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2204-2204
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top